{"id":3702,"date":"2021-02-04T18:05:15","date_gmt":"2021-02-05T02:05:15","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=3702"},"modified":"2021-02-04T18:05:15","modified_gmt":"2021-02-05T02:05:15","slug":"increased-hazard-of-death-in-community-tested-cases-of-sars-cov-2-variant-of-concern-20201201","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/02\/04\/increased-hazard-of-death-in-community-tested-cases-of-sars-cov-2-variant-of-concern-20201201\/","title":{"rendered":"Increased Hazard of Death in Community-Tested Cases of SARS-CoV-2 Variant of Concern 20201201"},"content":{"rendered":"<p><i>[Pre-print, not peer reviewed]<\/i> The SARS-CoV-2 B.1.1.7 variant (first identified in the UK) was estimated to increase the risk of death by 30%, based on an analysis of a database of SARS-CoV-2 community test results in the UK. This dataset represents approximately 47% of all SARS-CoV-2 community tests and 7% of COVID-19 deaths in England from September 1, 2020 to January 22, 2021. The authors identified B.1.1.7-associated infections using S gene target PCR failure.<\/p>\n<p><i>Davies et al. (Feb 3, 2021). Increased Hazard of Death in Community-Tested Cases of SARS-CoV-2 Variant of Concern 20201201. Pre-print downloaded Feb 4 from <\/i><a href=\"https:\/\/doi.org\/10.1101\/2021.02.01.21250959\">https:\/\/doi.org\/10.1101\/2021.02.01.21250959<\/a><i><span class=\"Apple-converted-space\">\u00a0<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Pre-print, not peer reviewed] The SARS-CoV-2 B.1.1.7 variant (first identified in the UK) was estimated to increase the risk of death by 30%, based on an analysis of a database of SARS-CoV-2 community test results in the UK. This dataset represents approximately 47% of all SARS-CoV-2 community tests and 7% of COVID-19 deaths in England&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/02\/04\/increased-hazard-of-death-in-community-tested-cases-of-sars-cov-2-variant-of-concern-20201201\/\">Read more<\/a><\/div>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[34,159],"topic":[20],"class_list":["post-3702","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-clinical-characteristics","tag-variants","topic-clinical-characteristics-and-health-care-setting"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/3702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=3702"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/3702\/revisions"}],"predecessor-version":[{"id":3703,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/3702\/revisions\/3703"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=3702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=3702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=3702"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=3702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}